Last month, we reported on recent motions to dismiss in suits alleging CBD companies were shortchanging customers by overstating the amount of CBD in their products. This month, we continue our coverage of the wave of CBD litigation by focusing on another subset of these cases: those alleging it is inherently illegal to sell CBD as a food, dietary supplement, or anything other than an FDA-approved drug. These cases assert state-law claims, such as unlawful competition and false advertising, and seek to halt CBD companies from selling CBD.
Please see full publication below for more information.
